Drug rehab serving Lantana — the specialist, 18 minutes away.

For Lantana, Hypoluxo Island, Manalapan, and Ocean Ridge residents, RECO is the closest clinically-led PHP and IOP program north of Broward — roughly 18 minutes down Federal Highway. Our addiction psychiatrists manage MAT in-house rather than referring out, and every client keeps the same primary therapist from detox through aftercare. Substance-specific protocols for opioids, stimulants, and sedatives, not a one-size curriculum.

Lantana sits in that quiet stretch of coastline between Delray Beach and West Palm Beach, where the Intracoastal narrows past Hypoluxo Island and Manalapan and the barrier-island communities thin out into Ocean Ridge. From Old Town Lantana, RECO Intensive is roughly eleven miles south down Federal Highway — about eighteen minutes on a normal afternoon, and often less if you take A1A and cross back over at Linton. For families on this stretch of the Palm Beach County coast looking for clinically-led drug rehab without driving to Broward or Miami, that proximity matters. Treatment that requires a forty-five minute commute each way is treatment people quietly stop attending. Treatment that’s a short drive down US-1 is treatment people actually complete.

RECO is an outpatient addiction treatment program built around the substances most common in South Florida: opioids (including fentanyl-contaminated heroin and prescription pills), cocaine and methamphetamine, benzodiazepines, alcohol, and the polysubstance combinations that have become more typical than single-substance use. Rather than running one generic curriculum and adjusting it at the edges, our clinical team uses substance-specific protocols at every level of care — medical detox, residential, partial hospitalization, and intensive outpatient — coordinated with a structured sober-living network when housing stability is part of the recovery picture.

Substance-specific clinical protocols

Opioid use disorder, stimulant use disorder, and sedative use disorder are not interchangeable diagnoses, and treating them as if they were is one of the quieter reasons people relapse. Opioid withdrawal is medically manageable but psychologically punishing, and the post-acute window — the weeks after the physical symptoms have resolved — is when most returns to use happen. Stimulant use disorder has no FDA-approved medication, which puts the entire weight of treatment on behavioral intervention, sleep restoration, and dopamine recovery over a longer arc. Benzodiazepine and other sedative dependence requires a slow, medically supervised taper because abrupt discontinuation can produce seizures.

RECO’s psychiatric and medical team builds different protocols for each. The opioid track integrates medication, contingency management, and trauma work. The stimulant track emphasizes circadian re-regulation, structured activity, and cognitive remediation in the early weeks when working memory hasn’t yet recovered. The benzodiazepine track is paced over months, not weeks, with cross-titration when clinically appropriate. The same building, the same therapists — but a treatment plan that actually reflects what the substance is doing to the brain in front of us.

Medication-assisted treatment where indicated

For clients with opioid use disorder, the evidence on medication-assisted treatment is settled: buprenorphine (Suboxone or Sublocade) and extended-release naltrexone (Vivitrol) reduce overdose mortality and improve retention in treatment. RECO’s in-house addiction psychiatrists initiate and manage MAT directly. That means induction happens within the program, dose adjustments happen in regular psychiatric appointments rather than at a separate clinic across town, and the medication conversation is integrated with the therapy conversation rather than running on a parallel track.

For alcohol use disorder, the options on the table include naltrexone (oral or extended-release injectable), acamprosate, and, in selected cases, disulfiram. The decision between them depends on drinking pattern, liver function, kidney function, and what the client is willing to take consistently. For clients in Lantana whose primary concern is alcohol rather than illicit drugs, our alcohol treatment page goes deeper into how those medications are sequenced with behavioral work. MAT is a tool, not the whole plan — but when it’s indicated and someone declines to offer it, that’s a clinical failure, not a philosophical position.

Behavioral therapy across the continuum

The therapeutic foundation is the boring, evidence-based core that the research has supported for two decades: Cognitive Behavioral Therapy for thought-pattern restructuring, Dialectical Behavior Therapy for emotion regulation and distress tolerance, Motivational Interviewing for ambivalence and the early stages of change, and Trauma-Focused CBT or EMDR for clients whose substance use sits on top of unresolved trauma. We use these because they work, not because they are fashionable.

What distinguishes RECO from many programs is therapeutic continuity. Every client is assigned a primary therapist on intake, and that therapist follows them through every level of care — from detox through residential through PHP through IOP and into the aftercare and alumni program. A client stepping down from residential care to PHP doesn’t retell their history to a new clinician. The therapist who knows their trauma narrative is the same therapist sitting across from them in week twelve. Fragmented care models — where each level of care comes with a new treatment team — create the gaps where people fall out of treatment. Continuity closes them.

Co-occurring mental health treatment

Roughly half to two-thirds of people entering addiction treatment also meet criteria for at least one other psychiatric condition: major depression, generalized anxiety, post-traumatic stress disorder, bipolar disorder, or ADHD most commonly. Treating the substance use disorder and ignoring the underlying psychiatric condition produces predictable results — early sobriety, decompensation around weeks four to eight, and return to use as self-medication.

RECO’s dual-diagnosis program treats both concurrently. Psychiatric evaluation happens in the first week, not after “thirty days clean.” Psychotropic medications are managed by addiction psychiatrists who understand the interaction between substance use, withdrawal physiology, and standard psychiatric pharmacology — which matters because, for example, stimulant withdrawal can mimic major depression for the first two to three weeks, and treating it prematurely with an antidepressant is the wrong move. The trauma-focused work, in particular, is paced carefully: clients who try to process trauma during acute withdrawal usually destabilize, so EMDR and trauma-focused CBT are sequenced once early stability is in place.

Insurance, admissions, and how to start from Lantana

RECO is in-network with most major commercial insurance carriers, including Aetna, Cigna, Blue Cross Blue Shield plans, Beacon, and most large employer plans. Florida Medicaid and Medicare are not currently accepted. A benefits check usually takes under an hour during business hours; the insurance verification page walks through what information you’ll need on hand. For clients whose primary concern is opioid use, our opioid-specific page covers detox and MAT in more detail.

Admissions calls are answered by clinicians, not a sales floor — so the conversation is a clinical screening, not a pitch. We will tell you honestly if RECO is not the right fit and refer accordingly. For most Lantana, Hypoluxo Island, Manalapan, and Ocean Ridge residents, the practical next step is a phone call to (866) 396-2008 for a clinical screen, a same-day benefits check, and, if appropriate, transport from your address down to our Delray Beach campus.

Serving residents of: Hypoluxo Island, Manalapan, Ocean Ridge, Old Town Lantana.